Home / Latest Reports / Intra Uterine Contraceptive Devices Market

Intra-Uterine Contraceptive Devices Market by Type, Products, and Application - Global Industry Analysis & Forecast to 2027

Published On : February 2020 Pages : 170 Category: Medical Devices Report Code : HC029281

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Intra-Uterine Contraceptive Devices Market by Type (Hormonal IUCD, Copper IUCD) Products (Mirena, Paragard, Essure, Skyla, Levosert, Others) Application (Hospitals and Private Clinics, Community Healthcare, Gynecology Clinics, Other) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The intra-uterine contraceptive devices market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. An intrauterine device (IUD), otherwise called an intrauterine preventative device (IUCD), is a little T-molded plastic device with copper united around the transverse arms, which is embedded into the uterus to prevent pregnancy. The IUD is one of the most famous contraceptive techniques, particularly for long haul reversible contraception, as it very well may be effectively fitted and evacuated.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global intra-uterine contraceptive devices market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Bayer AG
  • SMB Corporation and Meril Life Sciences Pvt. Ltd.
  • Teva Pharmaceuticals Industries
  • Medical Engineering Corporation SA
  • Melbea AG
  • Mona Lisa N.V.
  • Pregna International Limited
  • DKT International
  • Ocon Medical Ltd.
  • Egemen International

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Intra-Uterine Contraceptive Devices Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o    Hormonal IUCD

o    Copper IUCD

·         Intra-Uterine Contraceptive Devices Market, By Products, Estimates and Forecast, 2017-2027 ($Million)

o    Mirena

o    Paragard

o    Essure,

o    Skyla

o    Levosert

o    Others

·         Intra-Uterine Contraceptive Devices Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o    Hospitals and Private Clinics

o    Community Healthcare

o    Gynecology Clinics

o    Other

·         Intra-Uterine Contraceptive Devices Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Bayer AG

o    SMB Corporation and Meril Life Sciences Pvt. Ltd.

o    Teva Pharmaceuticals Industries

o    Medical Engineering Corporation SA

o    Melbea AG

o    Mona Lisa N.V.

o    Pregna International Limited

o    DKT International

o    Ocon Medical Ltd.

o    Egemen International

·         Intra-Uterine Contraceptive Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Intra-Uterine Contraceptive Devices Market, By Country

o    U.S. Intra-Uterine Contraceptive Devices Market

o    Canada Intra-Uterine Contraceptive Devices Market

o    Mexico Intra-Uterine Contraceptive Devices Market

o    Europe

§  Europe Intra-Uterine Contraceptive Devices Market, By Country

o    Germany Intra-Uterine Contraceptive Devices Market

o    UK Intra-Uterine Contraceptive Devices Market

o    France Intra-Uterine Contraceptive Devices Market

o    Russia Intra-Uterine Contraceptive Devices Market

o    Italy Intra-Uterine Contraceptive Devices Market

o    Rest of Europe Intra-Uterine Contraceptive Devices Market

o    Asia-Pacific

§  Asia-Pacific Intra-Uterine Contraceptive Devices Market, By Country

o    China Intra-Uterine Contraceptive Devices Market

o    Japan Intra-Uterine Contraceptive Devices Market

o    South Korea Intra-Uterine Contraceptive Devices Market

o    India Intra-Uterine Contraceptive Devices Market

o    Southeast Asia Intra-Uterine Contraceptive Devices Market

o    Rest of Asia-Pacific Intra-Uterine Contraceptive Devices Market

o    South America

§  South America Intra-Uterine Contraceptive Devices Market

o    Brazil Intra-Uterine Contraceptive Devices Market

o    Argentina Intra-Uterine Contraceptive Devices Market

o    Columbia Intra-Uterine Contraceptive Devices Market

o    Rest of South America Intra-Uterine Contraceptive Devices Market

o    Middle East and Africa

§  Middle East and Africa Intra-Uterine Contraceptive Devices Market

o    Saudi Arabia Intra-Uterine Contraceptive Devices Market

o    UAE Intra-Uterine Contraceptive Devices Market

o    Egypt Intra-Uterine Contraceptive Devices Market

o    Nigeria Intra-Uterine Contraceptive Devices Market

o    South Africa Intra-Uterine Contraceptive Devices Market

o    Rest of MEA Intra-Uterine Contraceptive Devices Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Intra-Uterine Contraceptive Devices Market, By Type

5.1.     Introduction

5.2.     Global Intra-Uterine Contraceptive Devices Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Intra-Uterine Contraceptive Devices Revenue and Revenue Share by Type (2017-2027)

5.3.     Hormonal IUCD

5.3.1.  Global Hormonal IUCD Revenue and Growth Rate (2017-2027)

5.4.     Copper IUCD

5.4.1.  Global Copper IUCD Revenue and Growth Rate (2017-2027)

6.       Intra-Uterine Contraceptive Devices Market, By Products

6.1.     Introduction

6.2.     Global Intra-Uterine Contraceptive Devices Revenue and Market Share by Products (2017-2027)

6.2.1.  Global Intra-Uterine Contraceptive Devices Revenue and Revenue Share by Products (2017-2027)

6.3.     Mirena

6.3.1.  Global Mirena Revenue and Growth Rate (2017-2027)

6.4.     Paragard

6.4.1.  Global Paragard Revenue and Growth Rate (2017-2027)

6.5.     Essure

6.5.1.  Global Essure  Revenue and Growth Rate (2017-2027)

6.6.     Skyla

6.6.1.  Global Skyla Revenue and Growth Rate (2017-2027)

6.7.     Levosert

6.7.1.  Global Levosert Revenue and Growth Rate (2017-2027)

6.8.     Others

6.8.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Intra-Uterine Contraceptive Devices Market, By Application

7.1.     Introduction

7.2.     Global Intra-Uterine Contraceptive Devices Revenue and Market Share by Application (2017-2027)

7.2.1.  Global Intra-Uterine Contraceptive Devices Revenue and Revenue Share by Application (2017-2027)

7.3.     Hospitals and Private Clinics

7.3.1.  Global Hospitals and Private Clinics Revenue and Growth Rate (2017-2027)

7.4.     Community Healthcare

7.4.1.  Global Community Healthcare Revenue and Growth Rate (2017-2027)

7.5.     Gynecology Clinics

7.5.1.  Global Gynecology Clinics Revenue and Growth Rate (2017-2027)

7.6.     Other

7.6.1.  Global Other Revenue and Growth Rate (2017-2027)

8.       Intra-Uterine Contraceptive Devices Market, By Region

8.1.     Introduction

8.2.     Global Intra-Uterine Contraceptive Devices Revenue and Market Share by Regions

8.2.1.  Global Intra-Uterine Contraceptive Devices Revenue by Regions (2017-2027)

8.3.     North America Intra-Uterine Contraceptive Devices by Countries

8.3.1.  North America Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2027)

8.3.2.  North America Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2027)

8.3.3.  United States

8.3.3.1.  United States Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.4.  Canada

8.3.4.1.  Canada Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5.  Mexico

8.3.5.1.  Mexico Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.     Europe Intra-Uterine Contraceptive Devices by Countries

8.4.1.  Europe Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2027)

8.4.2.  Europe Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2027)

8.4.3.  Germany

8.4.3.1.  Germany Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.4.  France

8.4.4.1.  France Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5.  UK

8.4.5.1.  UK Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  Russia

8.4.6.1.  Russia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  Italy

8.4.7.1.  Italy Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.     Asia-Pacific Intra-Uterine Contraceptive Devices by Countries

8.5.1.  Asia-Pacific Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2027)

8.5.3.  China

8.5.3.1.  China Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.4.  Japan

8.5.4.1.  Japan Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.  Korea

8.5.5.1.  Korea Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.  India

8.5.6.1.  India Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.     South America Intra-Uterine Contraceptive Devices by Countries

8.6.1.  South America Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2027)

8.6.2.  South America Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2027)

8.6.3.  Brazil

8.6.3.1.  Brazil Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.4.  Argentina

8.6.4.1.  Argentina Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5.  Columbia

8.6.5.1.  Columbia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.     Middle East and Africa Intra-Uterine Contraceptive Devices by Countries

8.7.1.  Middle East and Africa Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2027)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5.  Egypt

8.7.5.1.  Egypt Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  South Africa

8.7.7.1.  South Africa Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  Turkey

8.7.8.1.  Turkey Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.     Bayer AG

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.  Financial Overview

9.2.     SMB Corporation and Meril Life Sciences Pvt. Ltd.

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.  Financial Overview

9.3.     Teva Pharmaceuticals Industries

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.  Financial Overview

9.4.     Medical Engineering Corporation SA

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.  Financial Overview

9.5.     Melbea AG

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.  Financial Overview

9.6.     Mona Lisa N.V.

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.  Financial Overview

9.7.     Pregna International Limited

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.  Financial Overview

9.8.     DKT International

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.  Financial Overview

9.9.     Ocon Medical Ltd.

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.  Financial Overview

9.10. Egemen International

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.      Financial Overview

10.    Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.1. Global Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Intra-Uterine Contraceptive Devices Market Forecast by Regions (2017-2027)

10.2.1.      North America Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.1.1. United States Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.1.2. Canada Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.1.3. Mexico Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.2.      Europe Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.2.1. Germany Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.2.2. France Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.2.3. UK Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.2.4. Russia Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.2.5. Italy Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.3.1. China Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.3.2. Japan Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.3.3. Korea Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.3.4. India Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.4.      South America Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.4.1. Brazil Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.4.2. Argentina Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.4.3. Columbia Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.4.4. Rest of South America Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.3. Egypt Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.4. Nigeria Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.5. South Africa Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.6. Turkey Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Intra-Uterine Contraceptive Devices Market Forecast (2017-2027)

10.3. Intra-Uterine Contraceptive Devices Market Forecast by Type (2017-2027)

10.3.1.      Intra-Uterine Contraceptive Devices Forecast by Type (2017-2027)

10.3.2.      Intra-Uterine Contraceptive Devices Market Share Forecast by Type (2017-2027)

10.4. Intra-Uterine Contraceptive Devices Market Forecast by Products (2017-2027)

10.4.1.      Intra-Uterine Contraceptive Devices Forecast by Products (2017-2027)

10.4.2.      Intra-Uterine Contraceptive Devices Market Share Forecast by Products (2017-2027)

10.5. Intra-Uterine Contraceptive Devices Market Forecast by Application (2017-2027)

10.5.1.      Intra-Uterine Contraceptive Devices Forecast by Application (2017-2027)

10.5.2.      Intra-Uterine Contraceptive Devices Market Share Forecast by Application (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Intra-Uterine Contraceptive Devices Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Intra-Uterine Contraceptive Devices Revenue and Revenue Share by Type (2017-2018)
Figure Global Hormonal IUCD Revenue and Growth Rate (2017-2018)
Figure Global Copper IUCD Revenue and Growth Rate (2017-2018)
Table Global Intra-Uterine Contraceptive Devices Revenue and Revenue Share by Products (2017-2018)
Figure Global Mirena Revenue and Growth Rate (2017-2018)
Figure Global Paragard Revenue and Growth Rate (2017-2018)
Figure Global Essure Revenue and Growth Rate (2017-2018)
Figure Global Skyla Revenue and Growth Rate (2017-2018)
Figure Global Levosert Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Intra-Uterine Contraceptive Devices Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospitals and Private Clinics Revenue and Growth Rate (2017-2018)
Figure Global Community Healthcare Revenue and Growth Rate (2017-2018)
Figure Global Gynecology Clinics Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Intra-Uterine Contraceptive Devices Revenue by Regions (2017-2018)
Figure North America Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure North America Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2018)
Figure North America Intra-Uterine Contraceptive Devices by Countries (2017-2018)
Figure North America Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2018)
Figure United States Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure United States Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Canada Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Mexico Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Europe Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2018)
Figure Europe Intra-Uterine Contraceptive Devices by Countries (2017-2018)
Figure Europe Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2018)
Figure Germany Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Germany Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure France Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure UK Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Russia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Italy Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Rest of Europe Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Asia-Pacific Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Intra-Uterine Contraceptive Devices by Countries (2017-2018)
Figure Asia-Pacific Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2018)
Figure China Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure China Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Japan Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Korea Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure India Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Southeast Asia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure South America Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2018)
Figure South America Intra-Uterine Contraceptive Devices by Countries (2017-2018)
Figure South America Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Brazil Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Argentina Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Columbia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Rest of South America Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Middle East and Africa Intra-Uterine Contraceptive Devices Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Intra-Uterine Contraceptive Devices by Countries (2017-2018)
Figure Middle East and Africa Intra-Uterine Contraceptive Devices Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Saudi Arabia Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure United Arab Emirates Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Egypt Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Nigeria Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure South Africa Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Turkey Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Intra-Uterine Contraceptive Devices Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bayer AG Intra-Uterine Contraceptive Devices Financial Overview
Table SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Financial Overview
Table Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Financial Overview
Table Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Financial Overview
Table Melbea AG Intra-Uterine Contraceptive Devices Financial Overview
Table Mona Lisa N.V. Intra-Uterine Contraceptive Devices Financial Overview
Table Pregna International Limited Intra-Uterine Contraceptive Devices Financial Overview
Table DKT International Intra-Uterine Contraceptive Devices Financial Overview
Table Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Financial Overview
Table Egemen International Intra-Uterine Contraceptive Devices Financial Overview
Figure Global Intra-Uterine Contraceptive Devices Revenue (Millions USD) and Growth Rate (2018-2025)
Table Intra-Uterine Contraceptive Devices Market Forecast by Regions (2018-2025)
Figure North America Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure United States Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Canada Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Mexico Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Europe Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Germany Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure France Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure UK Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Russia Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Italy Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Rest of Europe Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Asia-Pacific Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure China Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Japan Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Korea Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure India Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Southeast Asia Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure South America Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Brazil Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Argentina Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Columbia Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Rest of South America Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Middle East and Africa Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Saudi Arabia Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure United Arab Emirates Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Egypt Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Nigeria Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure South Africa Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Turkey Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Intra-Uterine Contraceptive Devices Market Forecast (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Forecast by Type (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Market Share Forecast by Type (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Forecast by Type (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Forecast by Products (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Market Share Forecast by Products (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Forecast by Products (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Forecast by Application (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Market Share Forecast by Application (2018-2025)
Figure Global Intra-Uterine Contraceptive Devices Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample